{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:18:03Z","timestamp":1791011883635,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,10,7]],"date-time":"2008-10-07T00:00:00Z","timestamp":1223337600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s11255-008-9466-0","type":"journal-article","created":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T08:57:58Z","timestamp":1223283478000},"page":"163-169","source":"Crossref","is-referenced-by-count":11,"title":["Serum fibroblast growth factor-23 levels in chronic haemodialysis patients"],"prefix":"10.1007","volume":"41","author":[{"given":"Salwa","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,7]]},"reference":[{"key":"9466_CR1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","volume":"20","author":"N Itoh","year":"2004","unstructured":"Itoh N, Ornitz DM (2004) Evolution of FGF and FGF gene families. Trends Genet 20:563\u2013569. doi: 10.1016\/j.tig.2004.08.007","journal-title":"Trends Genet"},{"key":"9466_CR2","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T et al (2001) Cloning and characterization of FGF23 as a causative factor of tumor induced osteomalacia. Proc Natl Acad Sci USA 98:6500\u20136505. doi: 10.1073\/pnas.101545198","journal-title":"Proc Natl Acad Sci USA"},{"key":"9466_CR3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","volume":"277","author":"T Yamashita","year":"2000","unstructured":"Yamashita T, Yoshioka M, Itoh N (2000) Identification of a novel fibroblast growth factor, FGF23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 277:494\u2013498. doi: 10.1006\/bbrc.2000.3696","journal-title":"Biochem Biophys Res Commun"},{"key":"9466_CR4","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","volume":"278","author":"S Liu","year":"2003","unstructured":"Liu S, Guo R, Simpson LG et al (2003) Regulation of fibroblast growth factor 23 expression but not degradation by PHEX. J Biol Chem 278:37419\u201337426. doi: 10.1074\/jbc.M304544200","journal-title":"J Biol Chem"},{"key":"9466_CR5","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","volume":"291","author":"S Liu","year":"2006","unstructured":"Liu S, Zhou J, Tang W et al (2006) Pathogenic role of FGF23 in Hyp mice. Am J Physiol Endocrinol Metab 291:E38\u2013E49. doi: 10.1152\/ajpendo.00008.2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9466_CR6","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","volume":"18","author":"S Liu","year":"2007","unstructured":"Liu S, Quarles D (2007) How fibroblast growth factor 23 works. J Am Soc Nephrol 18:1637\u20131647. doi: 10.1681\/ASN.2007010068","journal-title":"J Am Soc Nephrol"},{"key":"9466_CR7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M","volume":"22","author":"DM Ornitz","year":"2000","unstructured":"Ornitz DM (2000) FGFs, heparan sulphate and FGFRs: complex interactions essential for development. Bioessays 22:108\u2013112. doi :10.1002\/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M","journal-title":"Bioessays"},{"key":"9466_CR8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T et al (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770\u2013774. doi: 10.1038\/nature05315","journal-title":"Nature"},{"key":"9466_CR9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y et al (2004) Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561\u2013568","journal-title":"J Clin Invest"},{"key":"9466_CR10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H et al (1997) Mutation of the mouse Klotho gene leads to a syndrome resembling aging. Nature 390:45\u201351. doi: 10.1038\/36285","journal-title":"Nature"},{"key":"9466_CR11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","volume":"17","author":"S Liu","year":"2006","unstructured":"Liu S, Tang W, Zhou J et al (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305\u20131315. doi: 10.1681\/ASN.2005111185","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"9466_CR12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s11255-007-9254-2","volume":"39","author":"BS Peters","year":"2007","unstructured":"Peters BS, Moyses RM, Jorgetti V et al (2007) Effects of Parathyroidectomy on bone remodelling markers and vitamin D status in patients with chronic kidney disease-mineral and bone disorder. Int Urol Nephrol 39(4):1251\u20131256. doi: 10.1007\/s11255-007-9254-2","journal-title":"Int Urol Nephrol"},{"key":"9466_CR13","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","volume":"280","author":"H Saito","year":"2005","unstructured":"Saito H, Maeda A, Ohtomo S et al (2005) Circulating FGF23 is regulated by 1 alpha, 25 dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280:2543\u20132549. doi: 10.1074\/jbc.M408903200","journal-title":"J Biol Chem"},{"key":"9466_CR14","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M et al (2002) Increased circulatory level of biologically active full length FGF23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab 87:4957\u20134960. doi: 10.1210\/jc.2002-021105","journal-title":"J Clin Endocrinol Metab"},{"key":"9466_CR15","unstructured":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification (2002) Am J Kidney Dis 39: S1\u2013S266"},{"key":"9466_CR16","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","volume":"64","author":"T Larsson","year":"2003","unstructured":"Larsson T, Nisbeth U, Ljunggren O et al (2003) Circulating concentration of FGF23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64:2272\u20132279. doi: 10.1046\/j.1523-1755.2003.00328.x","journal-title":"Kidney Int"},{"key":"9466_CR17","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1093\/ndt\/gfm347","volume":"22","author":"P Westerberg","year":"2007","unstructured":"Westerberg P, Linde T, Wikstrom B et al (2007) Regulation of fibroblast growth factor-23 in chronic kidney disease. Nephrol Dial Transplant 22:3202\u20133207. doi: 10.1093\/ndt\/gfm347","journal-title":"Nephrol Dial Transplant"},{"key":"9466_CR18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","volume":"44","author":"T Shigematsu","year":"2004","unstructured":"Shigematsu T, Kazama JJ, Yamashita T et al (2004) Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 44:250\u2013256. doi: 10.1053\/j.ajkd.2004.04.029","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"9466_CR19","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1523-1755.2004.00604.x","volume":"65","author":"Y Imanishi","year":"2004","unstructured":"Imanishi Y, Inaba M, Nakatsuka K et al (2004) FGF23 in patients with end-stage renal disease on hemodialysis. Kidney Int 65(5):1943\u20131946. doi: 10.1111\/j.1523-1755.2004.00604.x","journal-title":"Kidney Int"},{"key":"9466_CR20","doi-asserted-by":"crossref","first-page":"282A","DOI":"10.1097\/01.ASN.0000136132.20189.95","volume":"15","author":"N Okada","year":"2004","unstructured":"Okada N, Hayashi D, Tomida K et al (2004) Role of FGF23 in secondary hyperparathyroidism in patients with mild chronic kidney disease. J Am Soc Nephrol 15:282A. doi: 10.1097\/01.ASN.0000136132.20189.95","journal-title":"J Am Soc Nephrol"},{"key":"9466_CR21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.ki.5000168","volume":"69","author":"SC Schiavi","year":"2006","unstructured":"Schiavi SC (2006) Fibroblast growth factor 23: the making of a hormone. Kidney Int 69:425\u2013427. doi: 10.1038\/sj.ki.5000168","journal-title":"Kidney Int"},{"key":"9466_CR22","first-page":"S251","volume":"19","author":"F Perward","year":"2004","unstructured":"Perward F, Azam N, Zhang MYH et al (2004) Dietary phosphorus regulates serum FGF23 concentrations and 1,25 (OH)2D metabolism in mice. J Bone Miner Res 19:S251","journal-title":"J Bone Miner Res"},{"key":"9466_CR23","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/jc.2004-0724","volume":"89","author":"A Gupta","year":"2004","unstructured":"Gupta A, Winer K, Econs MJ et al (2004) FGF23 is elevated by chronic hyperphosphataemia. J Clin Endocrinol Metab 89:4489\u20134492. doi: 10.1210\/jc.2004-0724","journal-title":"J Clin Endocrinol Metab"},{"key":"9466_CR24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.ki.5002622","volume":"73","author":"P Urena-Torres","year":"2008","unstructured":"Urena-Torres P, Friedlander G, de Vernejoul MC et al (2008) Bone mass does not correlate with the serum fibroblast growth factor 23 in haemodialysis patients. Kidney Int 73:102\u2013107. doi: 10.1038\/sj.ki.5002622","journal-title":"Kidney Int"},{"key":"9466_CR25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ndt\/gfh701","volume":"20","author":"K Jonsson","year":"2005","unstructured":"Jonsson K (2005) The role of fibroblast growth factor 23 in renal disease. Nephrol Dial Transplant 20:479\u2013482. doi: 10.1093\/ndt\/gfh701","journal-title":"Nephrol Dial Transplant"},{"key":"9466_CR26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","volume":"67","author":"S Nakanishi","year":"2005","unstructured":"Nakanishi S, Kazama JJ, Nii-Kono T et al (2005) Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney Int 67:1171\u20131178. doi: 10.1111\/j.1523-1755.2005.00184.x","journal-title":"Kidney Int"},{"key":"9466_CR27","first-page":"282A","volume":"15","author":"JJ Kazama","year":"2004","unstructured":"Kazama JJ, Sato F, Omori K et al (2004) Pre-treatment serum FGF23 levels predict the efficacy of calcitriol therapy in dialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 15:282A","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"9466_CR28","first-page":"739","volume":"38","author":"M Wei","year":"2006","unstructured":"Wei M, Taskapan H, Esbaei K et al (2006) K\/DOQI guidelines requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them? Int Urol Nephrol 38(2):739\u2013743. doi: 10.1007\/s11255-006-0082-6","journal-title":"Int Urol Nephrol"},{"key":"9466_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/gfg458","volume":"19","author":"F Locatelli","year":"2004","unstructured":"Locatelli F, Pisoni RL, Combe C et al (2004) Anemia in hemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 19:121\u2013132. doi: 10.1093\/ndt\/gfg458","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"9466_CR30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11255-006-0081-7","volume":"38","author":"H Taskapan","year":"2006","unstructured":"Taskapan H, Wei M, Oreopoulos DG (2006) 25 (OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 38(2):317\u2013322. doi: 10.1007\/s11255-006-0081-7","journal-title":"Int Urol Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-008-9466-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-008-9466-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-008-9466-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:55:26Z","timestamp":1559390126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-008-9466-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["9466"],"URL":"https:\/\/doi.org\/10.1007\/s11255-008-9466-0","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,7]]}}}